Closed
0.65 1.56
24h
Min
0.61
Max
0.65
Income | 44M 7.3M |
---|---|
Sales | 5.1M 29M |
EPS | -0.15 |
Profit margin | 24.888 |
Employees | 61 |
EBITDA | 48M 17M |
Recommendations | Buy |
---|---|
12 Months Forecast | +642.19% upside |
Next Earnings | 8 maj 2025 |
---|
Market Cap | -30M 137M |
---|---|
Previous open | -0.91 |
Previous close | 0.65 |
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.75 USD 642.19%
High 7 USD
Low 1 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$